Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis

NCT04597775 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

93

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV Infection

Interventions

DRUG: hydroxychloroquine

Sponsor

Regional Center for Disease Control and Prevention, Jordan

Collaborators

[object Object]
[object Object]